Home > Insider Trading > Filing (0000911916-15-000189)

Filing Details

Accession Number:: 0000911916-15-000189
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-12 17:25:53
Reporting Period:: 2015-05-11

Filing Date:: 2015-05-12
Accepted Time:: 2015-05-12 17:25:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348649	Colucid Pharmaceuticals Inc.	CLCD	Pharmaceutical Preparations (2834)	203419541

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1189543	M Arthur Pappas	15 New England Executive Park Burlington MA 01803	Yes	No	Yes	No
1320654	A.m. Pappas & Associates, Llc	2520 Meridian Parkway, Suite 400 Durham NC 27713	No	No	Yes	No
1573854	A.m. Pappas Life Science Ventures Iii, L.p.	2520 Meridian Parkway, Suite 400 Durham NC 27713	No	No	Yes	No
1573873	Pv Iii Ceo Fund, L.p.	2520 Meridian Parkway, Suite 400 Durham NC 27713	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-05-11	1,588,607	$0.00	1,588,609	No	4	C	Indirect	By A. M. Pappas Life Science Ventures III, L.P.
Common Stock	Acquisiton	2015-05-11	98,757	$0.00	98,757	No	4	C	Indirect	By PV III CEO Fund, L.P.
Common Stock	Acquisiton	2015-05-11	282,440	$10.00	1,871,049	No	4	P	Indirect	By A. M. Pappas Life Science Ventures III, L.P.
Common Stock	Acquisiton	2015-05-11	17,560	$10.00	116,317	No	4	P	Indirect	By PV III CEO Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By A. M. Pappas Life Science Ventures III, L.P.
No	4	C	Indirect	By PV III CEO Fund, L.P.
No	4	P	Indirect	By A. M. Pappas Life Science Ventures III, L.P.
No	4	P	Indirect	By PV III CEO Fund, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2015-05-11	578,297	$0.00	578,297	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2015-05-11	35,953	$0.00	35,953	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2015-05-11	675,588	$0.00	675,588	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2015-05-11	41,996	$0.00	41,996	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2015-05-11	334,722	$0.00	334,722	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2015-05-11	20,808	$0.00	20,808	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,528	Indirect	By A.M. Pappas & Associates, LLC

Footnotes

Each share of Series A, Series B and Series C Convertible Preferred Stock was convertible at any time at the option of the holder, and converted automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering.
Represents securities held directly by A.M. Pappas Life Science Ventures III, L.P. AMP&A Management III, LLC is the general partner of A. M. Pappas Life Science Ventures III, L.P. and has a management agreement with A. M. Pappas & Associates, LLC. As a result, A. M. Pappas & Associates, LLC's investment committee has sole power to vote or to direct the vote of, and sole power to dispose or to direct the disposition of, all shares owned A.M. Pappas Life Science Ventures III, L.P. The reporting person is the sole managing member of A. M. Pappas & Associates, LLC. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Represents securities held directly by PV III CEO Fund, L.P. AMP&A Management III, LLC is the general partner of PV III CEO Fund, L.P. and has a management agreement with A. M. Pappas & Associates, LLC. As a result, A. M. Pappas & Associates, LLC's investment committee has sole power to vote or to direct the vote of, and sole power to dispose or to direct the disposition of, all shares owned PV III CEO Fund, L.P. The reporting person is the sole managing member of A. M. Pappas & Associates, LLC. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Represents securities held directly by A. M. Pappas & Associates, LLC. The reporting person is the sole managing member of A. M. Pappas & Associates, LLC. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The securities did not have an expiration date. The securities converted automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering.